2025 Regular Session • West Virginia Legislature
HB2349: To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone
Legislative Summary
The purpose of this bill is to require licensed programs, under the Medication-Assisted Treatment Program Licensing Act, to offer long-acting reversible contraception to patients recovering from addiction to new and current patients.
Demographic Impact
Overall analysis of equity impact
70% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/13/2025
Filed for introduction
House of Delegates
2/13/2025
To Health and Human Resources
House of Delegates
2/13/2025
Introduced in House
House of Delegates
2/13/2025
To House Health and Human Resources
House of Delegates
2/14/2025
To House Public Health
House of Delegates
3/5/2025
Markup Discussion
House of Delegates
3/13/2025
To House Health and Human Resources
House of Delegates
3/13/2025
Markup Discussion
House of Delegates
3/18/2025
By substitute, do pass
House of Delegates
3/19/2025
By substitute for substitute, do pass
House of Delegates
3/20/2025
On 1st reading, Special Calendar
House of Delegates
3/19/2025
Read 1st time
House of Delegates
3/20/2025
On 2nd reading, Special Calendar
House of Delegates
3/20/2025
Read 2nd time
House of Delegates
3/20/2025
Amendment reported by the Clerk
House of Delegates
3/20/2025
Amendment adopted (Voice vote)
House of Delegates
3/20/2025
Amendment reported by the Clerk
House of Delegates
3/20/2025
Amendment withdrawn (Voice vote)
House of Delegates
3/21/2025
On 3rd reading, Special Calendar
House of Delegates
3/21/2025
Read 3rd time
House of Delegates
3/21/2025
Passed House (Roll No. 132)
House of Delegates
3/21/2025
Communicated to Senate
House of Delegates
3/24/2025
Introduced in Senate
Senate
3/24/2025
To Health and Human Resources then Finance
Senate
3/24/2025
To Health and Human Resources
Senate
4/7/2025
Reported do pass, but first to Finance
Senate
4/7/2025
To Finance
Senate
4/9/2025
Reported do pass, with title amendment
Senate
4/9/2025
Immediate consideration
Senate
4/9/2025
Read 1st time
Senate
4/10/2025
On 2nd reading
Senate
4/10/2025
Read 2nd time
Senate
4/11/2025
On 3rd reading
Senate
4/11/2025
Laid over on 3rd reading 4/11/2025
Senate
Amendments
hb2349 s fin amt _1 4-9
hb2349 s fin amt _1 4-9
4/9/2025Not Adopted
hb2349 hfa worrell 3-20 _1
hb2349 hfa worrell 3-20 _1
3/20/2025Not Adopted
hb2349 hfa worrell 3-20 _1 adopted
hb2349 hfa worrell 3-20 _1 adopted
3/20/2025Adopted
hb2349 hfa pushkin 3-20
hb2349 hfa pushkin 3-20
3/20/2025Not Adopted
Roll Call Votes
Passed House (Roll No. 132)
3/21/2025
91
Yea
4
Nay
0
Not Voting
5
Absent
Result: PASSED
Status Information
Current Status
Engrossed(3/21/2025)
Chamber
Senate
